XL-184

Item no.	M1757-10mg
Manufacturer	AbMole
CASRN	849217-68-1
Amount	10mg
Category	Oncology Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Colorectal Cancer
Type	Inhibitors
Specific against	other
Purity	>99%
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Alias	Cabozantinib, BMS-907351，Cabometyx
Similar products	XL-184, Cabozantinib, BMS-907351
Available
Molecular Weight	501, 51
Solubility	DMSO 70 mg/mL
Bioactivity information	XL184 is a small molecule inhibits multiple receptor tyrosine kinases, specifically MET and VEGFR2 with IC50 values of 0.035 and 1.8 nM for VEGFR2 and Met respectively.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M1757-10mg-safety-datasheet.pdf